Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

Vogt Frederick G exercised options for 15,625 Iovance Biotherapeutics, Inc. shares (Form 4)

Traded Jun 5, 2026 · Filed Jun 9, 2026

On Jun 5, 2026, Vogt Frederick G (Director, Interim CEO & General Counsel) exercised options for 15,625 Iovance Biotherapeutics, Inc. shares, leaving 562,492 shares. Filed Jun 9, 2026 (Form 4).

Options exercised
15,625 shares
Holding after
562,492 shares
Trading plan
No
Role
Director, Interim CEO & General Counsel

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 5, 2026Common StockOption exercise15,625569,130Direct
Jun 5, 2026Common StockShares withheld for tax6,638US$4.23562,492Direct

Source

View original at SEC

Related